Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Defining the Role of the Gut Microbiome in Mediating the Effects of Obesity on Intestinal Stem Cells

NCT02863029 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT02863029
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02863029 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Defining the Role of the Gut Microbiome in Mediating the Effects of Obesity on Intestinal Stem Cells
Lead sponsor
Mayo Clinic
Phase
Not applicable
Overall status
Terminated
Start date
January 31, 2017
Completion date
March 9, 2017
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obesity